Histogen announced on Wednesday, Dr. Matthew Provencher and the Steadman Clinic received a $2 million award grant from the Department of Defense for clinical advancement of HST-003 for cartilage regeneration in the knee.
SAN DIEGO, Sept. 16, 2020, Histogen Inc., a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological function, has been awarded a $2 million grant by the Peer Reviewed Orthopedic Research Program (PRORP) of the U.S. Department of Defense (DoD) to help fund a Phase 1/2 clinical trial of HST-003 for regeneration of cartilage in the knee. The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick MD 21702, is the awarding and administering acquisition office.